Brief: Nova Mentis Files Genetic Neuroinflammatory Disease Patent
09/11/2021 14:14
Nov 9 (Reuters) - Nova Mentis Life Science Corp NOVA.CD :
* NOVA MENTIS FILES GENETIC NEUROINFLAMMATORY DISEASE PATENT
Source text for Eikon: ID:nPnY3t9pa
Further company coverage: NOVA.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Restart Life Sciences
See all newsBrief: Nova Mentis Announces Closing Of Non-Brokered Financing
Brief: Nova Mentis Files Genetic Neuroinflammatory Disease Patent
Brief: U.S. FDA Approves Nova Mentis Orphan Drug Application
Brief: Nova Mentis Launches Autism Clinical Study
Brief: Nova Mentis Life Science Says Co Approved For Trading On OTCQB Venture Market Effective Mar. 10